 |
|
|
|
|
|
|
|
|
|
|
|
1 to 30 of 71 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Mufson E. on PAPER: Deane R. et al., 2012, This most interesting paper presents a well-designed set of experiments, which provide evidence... 12 Apr 2012.
|
|
|
 |
|
|
Mufson E. on PAPER: Sperling RA. et al., 2011, Sperling and colleagues suggest that brain amyloid deposition drives the clinical sequelae... 13 Dec 2011.
|
|
|
|
|
|
Mufson E, Overk C. on NEWS: Hormone Replacement Therapy Latest Entry to AlzRisk Database, While hormone therapy is the most effective treatment for vasomotor symptoms associated with... 4 Nov 2011.
|
|
|
|
|
|
Mufson E. on NEWS: Anti-Aβ Oligomer Headed for Phase 3 Clinical Trial, These types of press releases and hyped reviews only give false hope to the public. The AD... 1 Sep 2010.
|
|
|
|
|
|
Mufson E. on PAPER: Decker H. et al., 2010, This is an interesting and well-presented study, but as with many studies of Aβ toxicity, the... 22 Jul 2010.
|
|
|
|
|
|
Mufson E. on PAPER: de Calignon A. et al., 2010, The findings of Alix de Calignon and colleagues are interesting and support several studies... 15 Apr 2010.
|
|
|
|
|
|
Counts S, Mufson E. on PAPER: Rohe M. et al., 2009, The article by Rohe and colleagues presents data derived from in vivo and in vitro studies... 21 Dec 2009.
|
|
|
|
|
|
Mufson E. on NEWS: Paper Alert-cum-SfN: Bapineuzumab Published, More AN1792 Presented, This may be a naive question, but if amyloid deposition in the brain is a critical factor in... 1 Dec 2009.
|
|
|
|
|
|
Mufson E. on PAPER: Sotthibundhu A. et al., 2008, Recommendation Only. 2 Jul 2009.
|
|
|
|
|
|
Mufson E. on PAPER: Soscia SJ. et al., 2010, This interesting concept could begin to explain the widespread amyloid response in AD and in... 7 Apr 2009.
|
|
|
|
|
|
Ginsberg S, Mufson E. on NEWS: AD Clinical Pipeline: Immunotherapy Woes, Dimebon Boons, This paper is a jarring wake-up call to all Alzheimer disease investigators that placed all... 8 Aug 2008.
|
|
|
|
|
|
Mufson E. on PAPER: Jang SW. et al., 2007, The neurotrophin nerve growth factor (NGF) and its high-affinity receptor TrkA play a major role... 5 Oct 2007.
|
|
|
|
|
|
Mufson E. on NEWS: eFAD Research Surprise: In Mutation Carriers, Amyloid Starts in Striatum, The work by Klunk and coworkers (2007) demonstrates how incomplete our understanding is of the... 21 Jun 2007.
|
|
|
|
|
|
Mufson E. on NEWS: Salzburg Overview: 8th International Conference Draws Record Number, I was a speaker at the AD/PD meeting in Salzburg. My congratulations go out to the organizers of... 2 Apr 2007.
|
|
|
|
|
|
Mufson E. on PAPER: Dorsey SG. et al., 2006, The articles by Dorsey and colleagues and Mobley's group (see Salehi et al., 2006) are... 8 Dec 2006.
|
|
|
|
|
|
Mufson E. on NEWS: Looking outside the Brain for Early Signs of AD, The search for a biomarker that distinguishes AD from other neurological dementias is a fertile... 4 Oct 2005.
|
|
|
|
|
|
Mufson E. on PAPER: Rösch H. et al., 2005, Rosch and colleagues in the May 17 issue of PNAS provide intriguing new data implicating p75NTR... 29 Jun 2005.
|
|
|
|
|
|
Mufson E. on PAPER: Andorfer C. et al., 2005, This is a most interesting and provocative study. It adds yet another wrinkle to the AD... 20 Jun 2005.
|
|
|
|
|
|
Mufson E. on NEWS: Huntingtin, BDNF, Neurodegeneration: Is Speed of the Essence?, The findings of decreased BDNF transport in Huntington's disease, as well as the reports by the... 27 Jul 2004.
|
|
|
|
|
|
Mufson E. on PAPER: Takashima S. et al., 1997, Good review. No date saved.
|
|
|
|
|
|
Mufson E. on PAPER: Kim TW. et al., 1997, Interesting No date saved.
|
|
|
|
|
|
Mufson E. on PAPER: Lopez-Alberola RF. et al., 1997, Interesting No date saved.
|
|
|
|
|
|
Mufson E. on PAPER: Kamboh MI. et al., 1997, Interesting No date saved.
|
|
|
|
|
|
Mufson E. on PAPER: Samuel W. et al., 1997, Interesting study. No date saved.
|
|
|
|
|
|
Mufson E. on PAPER: Vincent I. et al., 1997, Interesting. No date saved.
|
|
|
|
|
|
Mufson E. on PAPER: Hibbard LS. et al., 1997, Noteworthy. No date saved.
|
|
|
|
|
|
Mufson E. on PAPER: Guo Q. et al., 1996, Interesting No date saved.
|
|
|
|
|
|
Mufson E. on PAPER: Lopez OL. et al., 1997, Interesting No date saved.
|
|
|
|
|
|
Mufson E. on PAPER: Jicha GA. et al., 1997, Noteworthy. No date saved.
|
|
|
|
|
|
Mufson E. on PAPER: Beard CM. et al., 1997, Interesting No date saved.
|
|
|
|
|
|
|
1 to 30 of 71 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
See our latest Webinar: 
